Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 9)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Earlier Type 2 Diabetes Diagnoses Bring Higher Odds for Dementia
WEDNESDAY, Nov. 20, 2024 -- A type 2 diabetes diagnosis before age 50 comes with a health risk that patients might not expect. Especially if they are obese, these folks are more likely to develop ...
AHA: Intensive Strategy for Lowering Systolic BP Beneficial in Type 2 Diabetes
WEDNESDAY, Nov. 20, 2024 – For patients with type 2 diabetes and elevated systolic blood pressure, an intensive-treatment strategy is better than a standard-treatment strategy for incidence of major...
Metformin Use Tied to Lower Rate of Asthma Attacks
MONDAY, Nov. 18, 2024 – Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published online Nov. 18 in JAMA Internal Medicine. Bohee Lee, ...
More Than Half of U.S. Adults Could Be Candidates for Ozempic
TUESDAY, Nov. 19, 2024 – More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Sold as Ozempic for...
Risk for Mortality Up With Low Income in Type 2 Diabetes
FRIDAY, Nov. 15, 2024 – Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years,...
Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes
MONDAY, Nov. 18, 2024 – For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes,...
AHA: AI Analysis of Images, Videos Can ID Early Hypertension, Diabetes
MONDAY, Nov. 18, 2024 – Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes, according to a study presented at the...
Diabetes Meds Metformin, GLP-1s Can Also Curb Asthma
MONDAY, Nov. 18, 2024 – Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows. The two drugs are metformin, one of...
Burden of Diabetes, Untreated Diabetes Increased From 1990 to 2022
FRIDAY, Nov. 15, 2024 – The global burden of diabetes and untreated diabetes increased from 1990 to 2022, according to a study published online Nov. 13 in The Lancet. Bin Zhou, Ph.D., from Imperial...
Gum Disease & Diabetes: A Strong Link
THURSDAY, Nov. 14, 2024 – Periodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn. “Recent research has shown that diabetes is not only ...
More Than 800 Million People Worldwide Now Have Diabetes
THURSDAY, Nov. 14, 2024 – Fourteen percent of the world's people – more than 800 million – now have diabetes, a doubling of the global rate for the blood sugar disease since 1990, new statistics...
ASH: GLP-1 RA Use Tied to Lower Rate of Venous Thromboembolism in Diabetes
THURSDAY, Nov. 14, 2024 – For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE),...
Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier
MONDAY, Nov. 11, 2024 – People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says. Men with both diabetes and kidney disease will develop heart...
Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death
MONDAY, Nov. 11, 2024 – The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 diabetes m...
Prevalence of Diabetes 15.8 Percent in U.S. Adults From 2021 to 2023
WEDNESDAY, Nov. 6, 2024 – The prevalence of diabetes was 15.8 percent among U.S. adults during August 2021 to August 2023, according to a November data brief published by the National Center for...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Mounjaro, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... Farxiga, Jardiance, Lantus Solostar, Humalog, Novolog, liraglutide, Janumet, insulin glargine, tirzepatide, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, dulaglutide, Glucophage, Invokana, insulin degludec, Humulin N